Skip to main content
Sasha Bernatsky, MD PhD

Sasha Bernatsky, MD PhD

2010 recipient of the Mary Betty Stevens Young Investigator Prize

Dr. Bernatsky, a rheumatologist, is the James McGill Professor and a senior scientist in the Centre for Health Outcomes Research and Division of Clinical Epidemiology at the Research Institute of the McGill University Health Center in Montreal, Canada.

Dr. Bernatsky's research focuses on an international cohort study of cancer and mortality in lupus, with a particular emphasis on identifying risk factors for developing cancer among patients with lupus. She is author or co-author of over 300 peer-reviewed medical journal articles. She has received many awards, including the Arthritis Alliance of Canada's KT Practice Award.

She is considered an expert in using extensive national and international data sets linked to additional clinical sources of information.  Her work also encompasses studying drug exposures in diseases, and their impact on morbidity, mortality, and economic outcomes. 

Her work on drug safety and effectiveness includes a large Drug Safety and Effectiveness Network (DSEN)-funded study in Canada of patients receiving biosimilar agents and their legacy drugs. Dr. Bernatsky is also a mentor within the Canadian Institutes of Health Research (CIHR) Drug Safety and Effectiveness Cross-Disciplinary Training Program. It provides drug safety and effectiveness training for future scientists in Canada.

The Lupus Foundation of America recognized Dr. Bernatsky in 2010 when she received the Mary Betty Stevens Young Investigator Prize for her work in lupus.